| | |
| Clinical data | |
|---|---|
| ATC code |
|
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| UNII | |
| Chemical and physical data | |
| Formula | C14H16F3NO |
| Molar mass | 271.283 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Trifluoromethyldeschloroketamine (TFMDCK) is a designer drug from the arylcyclohexylamine family, which is presumed to have similar properties to ketamine, a dissociative anesthetic drug with hallucinogenic and sedative effects. [1] It has been sold over the internet since around 2016, though genuine samples appear to be rare. [2] The o-trifluoromethyl analogue of hydroxynorketamine has also been researched as an antidepressant. [3]